Scheitz et al.[7] found that statin therapy in ischemic stroke patients treated with thrombolytic agents also reduced the risk of poststroke infection, suggesting a possible interaction between tissue plasminogen activator (tPA) and statins. The gene discussed is PLAT; the disease is ischemic stroke.